Advanced Enzyme Technologies Limited (ADVENZYMES) — share transfer | 14 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
SEBI Regulation 74(5) certificate issued for quarter ended June 30, 2026
💡 Investor Takeaway
This confirms routine compliance with share transfer regulations and validates the company's registrar operations.

Advanced Enzyme Technologies Limited received a SEBI-mandated share transfer agent certificate for the quarter ended June 30, 2026, confirming dematerialization of securities and their listing on Indian exchanges. The filing details verification of transferred shares and updates to the shareholder register by MUFG Intime India Private Limited, the company's registrar.

📄 View Original Announcement (PDF)

About Advanced Enzyme Technologies Limited (ADVENZYMES)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,071.34 Cr P/E: 24.1 ROE: 10.3% ROCE: 13.8%

View full ADVENZYMES stock details →

📡 Get AI alerts when ADVENZYMES files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ADVENZYMES — Free

📊 More ADVENZYMES filings

See all ADVENZYMES filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ADVENZYMES files new disclosures

Track ADVENZYMES filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ADVENZYMES — Free

Free account · 2 AI queries/day